India, May 12 -- Marty Makary is stepping down from his role as commissioner of the U.S. Food and Drug Administration after a little more than a year, wrapping up a tenure marked by internal conflict and criticism from notable organisations.
Makary, a surgeon and health policy researcher, came to prominence during the COVID-19 pandemic as a vocal opponent of public health restrictions and often appeared on Fox News. He was appointed to lead the FDA during President Donald Trump's second term.
Throughout his time in this position, he launched initiatives to speed up drug approvals, such as promoting the use of artificial intelligence in regulatory processes and simplifying clinical study requirements. Still, these efforts were often oversh...